Health
Pfizer, BioNTech propose expanding Covid-19 vaccine trial to 44,000 volunteers – Hindustan Times
The initial target figure for the trial was up to 30,000 participants, which the companies said they expect to reach by next week.
Pfizer Inc and BioNTech SE on Saturday proposed to the US Food and Drug Administration (FDA) to expand their Phase 3 pivotal Covid-19 vaccine trial to about 44,000 participants while increasing the diversity of the trial population.
The initial target figure for the trial was up to 30,000 participants, which the companies said they expect to reach by next week.
The proposed expansion would also allow the companies to enroll people as young as 16 and people with chronic, stable HIV, hepatitis C…
-
General24 hours agoStewards placed hundreds of bets on Tasmanian races, integrity investigation finds
-
Noosa News19 hours agoNRL finals live updates: Melbourne Storm vs Canterbury Bulldogs — blog, scores and stats
-
Noosa News20 hours agoStolen hearse crashes into two cars in peak-hour collision at Parkwood on the Gold Coast
-
General18 hours agoPrince Harry arrives in Kyiv to meet with wounded Ukrainian war veterans